Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 2001 Oct 9;57(7):1313-6.
doi: 10.1212/wnl.57.7.1313.

Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy

G Schifitto  1 , C Yiannoutsos, D M Simpson, B T Adornato, E J Singer, H Hollander, C M Marra, M Rubin, B A Cohen, T Tucker, I J Koralnik, D Katzenstein, B Haidich, M E Smith, S Shriver, L Millar, D B Clifford, J C McArthur; AIDS Clinical Trials Group Team 291
Affiliations
Clinical Trial

Long-term treatment with recombinant nerve growth factor for HIV-associated sensory neuropathy

G Schifitto et al. Neurology. .

Abstract

HIV-associated distal sensory polyneuropathy (DSP) is a common complication of AIDS. No effective treatment is available. The authors investigated the long-term effect (48 weeks) of the neurotrophin nerve growth factor (NGF) in an open-label study of 200 subjects with HIV-associated DSP. Similar to their previously reported double-blind study, the authors showed that NGF was safe and well tolerated and significantly improved pain symptoms. However, there was no improvement of neuropathy severity as assessed by neurologic examination, quantitative sensory testing, and epidermal nerve fiber density.

PubMed Disclaimer

Publication types

MeSH terms